(E)-beta-Santalol is a sesquiterpene alcohol reported as a minor constituent in essential-oil GC-MS profiles.
Aroma and practical use
No aroma description is attached to this identity yet.
- Review the flagged use concerns across every contributing oil and the selected dilution.
Reported benefits and effects
Findings retain their study context. An animal or laboratory result describes that experiment.
There are no constituent-specific outcome findings in this report. No therapeutic benefit is inferred from its presence.
Use concerns and concentration limits
Sensitization concernFlagged
Flagged in the constituent reference; assess the source, route and finished-product concentration.
Phototoxicity concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Oxidation concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Penetration enhancementNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
No numeric constituent-specific use limit is available here. Missing is not an unrestricted-use clearance.
Constituents it may interact with
No constituent-pair interaction is recorded for this identity. The report does not assume either amplification or incompatibility.
What this report cannot establish
- A reported constituent percentage does not establish an effective human therapeutic dose or the amount absorbed into the body.
- The presence of a constituent does not guarantee a clinical benefit, rash treatment or sleep improvement from a custom blend.
- An unflagged concern or missing use limit does not establish safety for ingestion, inhalation, skin exposure or a particular person.
- A candidate constituent interaction does not establish that two oils amplify one another at the selected proportions.
- Constituent descriptors alone do not establish a precise top, heart or base lifetime in a finished blend.
Known data gaps (6)
- Minor GC-MS constituent added during composition completion; profile/SEO detail pending.
- cas remains null (2026-07-13): CAS 77-42-9 is documented for beta-santalol generally (commonly the natural (Z)-configured isomer predominant in sandalwood oil); no source confirmed a distinct CAS specifically for the (E)-stereoisomer, so assigning 77-42-9 here would risk misattributing stereochemistry.
- dermal_limit_pct stays null and dermal_limit_verified stays false (2026-07-13): no isomer-specific IFRA numeric limit was located. Additional context found: EU SCCS categorizes Australian sandalwood oil as an established contact allergen due to santalol content; diagnostic patch testing at up to 10% santalol showed 0.0071-1.53% positive-reaction incidence, but a human maximization test at 20% in 25 male volunteers showed no sensitization, so the sensitizing signal is real but concentration-dependent and mixed rather than a settled monograph value.
- No constituent-specific outcome findings are available in this report.
- No cited aroma description is available for this identity.
- No constituent-specific numeric dermal reference is available here.